Single-Domain Antibodies As Therapeutics against Human Viral Diseases
Author:
Funder
National Natural Science Foundation of China
Publisher
Frontiers Media SA
Subject
Immunology,Immunology and Allergy
Reference123 articles.
1. Antibodies to watch in 2017;Reichert;mAbs,2017
2. Building better monoclonal antibody-based therapeutics;Weiner;Nat Rev Cancer,2015
3. Palivizumab;Scott;Drugs,1999
4. Challenges in monoclonal antibody-based therapies;Samaranayake;Ann Med,2009
5. Engineered antibody fragments and the rise of single domains;Holliger;Nat Biotech,2005
Cited by 87 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Structural trends in antibody-antigen binding interfaces: a computational analysis of 1833 experimentally determined 3D structures;Computational and Structural Biotechnology Journal;2024-12
2. Mass spectrometry-complemented molecular modeling predicts the interaction interface for a camelid single-domain antibody targeting the Plasmodium falciparum circumsporozoite protein’s C-terminal domain;Computational and Structural Biotechnology Journal;2024-12
3. Development of a broad-spectrum therapeutic Fc-nanobody for human noroviruses;Journal of Virology;2024-07-23
4. Single-domain antibodies as therapeutics for solid tumor treatment;Acta Pharmaceutica Sinica B;2024-07
5. Reversal of carbapenem resistance in Pseudomonas aeruginosa by camelid single domain antibody fragment (VHH) against the C4-dicarboxylate transporter;The Journal of Antibiotics;2024-06-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3